UCB (UCB)

Index:

BEL 20

  250.20
   
  • Change Today:
     4.40
  • 52 Week High:  275.00
  • 52 Week Low:  178.85
  • Currency: Euro
  • Shares Issued: 190.00m
  • Volume: 227,096
  • Market Cap:  47,538m
  • Beta: 0.01

Latest ShareCast News

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

By Michele Maatouk

Date: Thursday 10 Oct 2019

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.

UCB ShareCast News

No recent information was found.

UCB Newspaper Links

GSK gets emerging markets boost with UCB deal 24-Jan-2009 Telegraph
UCB confident on drug go-ahead 21-Aug-2007 The Scotsman
Fellner shuffles Acambis board 08-Mar-2007 Telegraph
Deal speeds drugs sector consolidation 26-Sep-2006 The Herald

UCB Tips & Analysis

No recent information was found.

UCB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

UCB Market Data

Currency Euro
Share Price   250.20
Change Today   4.40
% Change 1.79 %
52 Week High  275.00
52 Week Low  178.85
Volume 227,096
Shares Issued 190.00m
Market Cap  47,538m
Beta 0.01

Trades for 28-Jul-2026

Time Volume / Share Price
17:35 138 @  250.20
17:35 248 @  250.20
17:35 220 @  250.20
17:35 187 @  250.20
17:35 3 @  250.20

Top of Page